Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Fusion Pharmaceuticals Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +3 vs. Q1 2023
- Shares held
- 50.3M
- +4.68M (+10.3%) vs. Q1 2023
- Total value
- $235.1M
- +$63.1M (+36.7%) vs. Q1 2023
- New holders
- 5
- 10 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 10,633,789 | $49.8M | 0.12% | +4,784,689+81.8% | Added |
| Avidity Partners Management LP | 5,700,000 | $26.6M | 0.93% | 00.0% | Unchanged |
| FMR LLC | 4,681,457 | $21.9M | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 3,670,516 | $17.1M | 5.32% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $14.6M | 0.02% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,122,770 | $14.6M | 0.28% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $13.8M | 3.60% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,823,000 | $13.2M | 0.28% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,751,395 | $12.8M | 0.37% | −8,541−0.3% | Reduced |
| TPG GP A, LLC | 2,551,794 | $11.9M | 0.17% | 00.0% | Unchanged |
| Artal Group S.A. | 1,725,000 | $8.06M | 0.26% | −250,000−12.7% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $7.29M | 2.40% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,329,258 | $6.21M | 1.33% | +45,721+3.6% | Added |
| 1832 Asset Management L.P. | 734,321 | $3.43M | 0.01% | 00.0% | Unchanged |
| Eagle Health Investments LP | 680,370 | $3.18M | 0.59% | +680,370 | New |
| Ghost Tree Capital, LLC | 412,699 | $1.93M | 0.70% | +62,699+17.9% | Added |
| Millennium Management LLC | 334,577 | $1.56M | 0.00% | −69,211−17.1% | Reduced |
| Point72 Asset Management, L.P. | 328,868 | $1.54M | 0.01% | 00.0% | Unchanged |
| UBS Oconnor LLC | 274,568 | $1.28M | 0.03% | +32,542+13.4% | Added |
| Sio Capital Management, LLC | 246,036 | $1.15M | 0.41% | 00.0% | Unchanged |
| Morgan Stanley | 137,611 | $642.6K | 0.00% | +19,376+16.4% | Added |
| Sofinnova Investments, Inc. | 117,099 | $546.9K | 0.04% | 00.0% | Unchanged |
| UBS Group AG | 93,960 | $438.8K | 0.00% | +4,174+4.6% | Added |
| Two Sigma Advisers, LP | 65,400 | $305.4K | 0.00% | +29,500+82.2% | Added |
| Sectoral Asset Management Inc | 57,297 | $267.6K | 0.04% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $203.1K | 0.01% | 00.0% | Unchanged |
| Leonteq Securities AG | 35,000 | $163.8K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 31,154 | $145.5K | 0.00% | −13,673−30.5% | Reduced |
| Geode Capital Management, LLC | 30,374 | $142.2K | 0.00% | +5,238+20.8% | Added |
| Forefront Analytics, LLC | 20,075 | $93.8K | 0.05% | +20,075 | New |
| Schonfeld Strategic Advisors LLC | 14,800 | $69.1K | 0.00% | +1,700+13.0% | Added |
| BlackRock Inc. | 8,253 | $38.5K | 0.00% | 00.0% | Unchanged |
| Dorsey Wright & Associates | 4,889 | $22.9K | 0.01% | +4,889 | New |
| Bank of America Corp | 2,325 | $10.9K | 0.00% | +2,325 | New |
| Royal Bank of Canada | 1,839 | $9.00K | 0.00% | −364−16.5% | Reduced |
| Simplex Trading, LLC | 1,401 | $6.00K | 0.00% | +942+205.2% | Added |
| TD Waterhouse Canada Inc. | 700 | $3.23K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $1.40K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 100 | $467 | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 30 | $140 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $9 | 0.00% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −659,992−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,084−100.0% | Sold out |